Tolterodine Extended Release Capsule

tolterodine · Pfizer Upjohn / Viatris (Pfizer's Upjohn merged with Mylan to form Viatris Inc.)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tolterodine Extended Release Capsule, covering 2021-01-27 to 2021-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet [Phase 3]

See pricing